- Home
- MDXG vs ATRC Comparison
MDXG vs ATRC Comparison
Compare MDXG & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- ATRC
- Stock Information
- Founded
- MDXG 2006
- ATRC 2000
- Country
- MDXG United States
- ATRC United States
- Employees
- MDXG N/A
- ATRC N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- ATRC Medical/Dental Instruments
- Sector
- MDXG Health Care
- ATRC Health Care
- Exchange
- MDXG Nasdaq
- ATRC Nasdaq
- Market Cap
- MDXG 1.3B
- ATRC 1.1B
- IPO Year
- MDXG N/A
- ATRC 2005
- Fundamental
- Price
- MDXG $8.47
- ATRC $40.75
- Analyst Decision
- MDXG Strong Buy
- ATRC Strong Buy
- Analyst Count
- MDXG 5
- ATRC 9
- Target Price
- MDXG $12.00
- ATRC $43.00
- AVG Volume (30 Days)
- MDXG 617.6K
- ATRC 618.4K
- Earning Date
- MDXG 02-26-2025
- ATRC 02-12-2025
- Dividend Yield
- MDXG N/A
- ATRC N/A
- EPS Growth
- MDXG N/A
- ATRC N/A
- EPS
- MDXG 0.52
- ATRC N/A
- Revenue
- MDXG $342,804,000.00
- ATRC $447,573,000.00
- Revenue This Year
- MDXG $9.56
- ATRC $18.02
- Revenue Next Year
- MDXG $9.19
- ATRC $12.93
- P/E Ratio
- MDXG $16.49
- ATRC N/A
- Revenue Growth
- MDXG 10.93
- ATRC 17.56
- 52 Week Low
- MDXG $5.47
- ATRC $18.94
- 52 Week High
- MDXG $10.14
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- MDXG 41.31
- ATRC 61.66
- Support Level
- MDXG $8.29
- ATRC $39.71
- Resistance Level
- MDXG $9.30
- ATRC $43.11
- Average True Range (ATR)
- MDXG 0.30
- ATRC 1.86
- MACD
- MDXG -0.04
- ATRC 0.15
- Stochastic Oscillator
- MDXG 27.10
- ATRC 63.10
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.